Mark Christopher Capone Acquires 10,000 Shares of Myriad Genetics Inc. (MYGN) Stock
Myriad Genetics Inc. insider Mark Christopher Capone acquired 10,000 shares of the firm's stock in a transaction dated Friday, August 19th. The shares were purchased at an average price of $21.24 per share, with a total value of $212,400.00.
from Biotech News
0 Comments